These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage. Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297 [TBL] [Abstract][Full Text] [Related]
3. The attack phase of human complement: differentiation between membrane binding and complex formation by the detection of neoantigen expression in situ. A morphometric immunoferritin study. Balkarowa-Ständer J; Rother U; Rauterberg EW J Immunol; 1981 Sep; 127(3):1089-93. PubMed ID: 7264298 [TBL] [Abstract][Full Text] [Related]
4. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a. Hammer CH; Hänsch G; Gresham HD; Shin ML J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934 [TBL] [Abstract][Full Text] [Related]
5. Deviated lysis: transfer of complement lytic activity to unsensitized cells. IV. Parital isolation of the activity. Hänsch G; Rother U; Rother K Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):48-59. PubMed ID: 868206 [TBL] [Abstract][Full Text] [Related]
6. Terminal complement components play a role in the expression of C5a. Gresham HD; Renfer L; Hammer CH; Frank MM J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718 [TBL] [Abstract][Full Text] [Related]
7. Complement lysis: the ultrastructure and orientation of the C5b-9 complex on target sheep erythrocyte membranes. Tranum-Jensen J; Bhakdi S; Bhakdi-Lehnen B; Bjerrum OJ; Speth V Scand J Immunol; 1978; 7(1):45-6. PubMed ID: 635472 [TBL] [Abstract][Full Text] [Related]
8. The structural events associated with the attachment of complement components to cell membranes in reactive lysis. Dourmashkin RR Immunology; 1978 Aug; 35(2):205-12. PubMed ID: 750370 [TBL] [Abstract][Full Text] [Related]
9. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9. Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861 [TBL] [Abstract][Full Text] [Related]
10. Determination of the number of lytic sites in biconcave and spheroid erythrocyte ghosts after complement lysis. Bauer J; Podack ER; Valet G J Immunol; 1979 May; 122(5):2032-6. PubMed ID: 448115 [No Abstract] [Full Text] [Related]
11. Deviated lysis: transfer of complement lytic activity to unsensitized cells. I. Generation of the transferable activity on the surface of complement resistant bacteria. Rother U; Hänsch G; Menzel J; Rother K Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):172-86. PubMed ID: 4283273 [No Abstract] [Full Text] [Related]
12. Restriction of complement-mediated membrane damage by the eighth component of complement: a dual role for C8 in the complement attack sequence. Nemerow GR; Yamamoto KI; Lint TF J Immunol; 1979 Sep; 123(3):1245-52. PubMed ID: 469249 [No Abstract] [Full Text] [Related]
13. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement. Stewart JL; Kolb WP; Sodetz JM J Immunol; 1987 Sep; 139(6):1960-4. PubMed ID: 3624872 [TBL] [Abstract][Full Text] [Related]
14. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b. Rosenfeld SI; Jenkins DE; Leddy JP J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820 [TBL] [Abstract][Full Text] [Related]
15. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane. Joiner KA; Hammer CH; Brown EJ; Frank MM J Exp Med; 1982 Mar; 155(3):809-19. PubMed ID: 6801180 [TBL] [Abstract][Full Text] [Related]
16. Functional properties of the asialo-fifth component of human complement. Schultz DR; Arnold PI J Immunol; 1990 Jul; 145(2):655-61. PubMed ID: 2114446 [TBL] [Abstract][Full Text] [Related]
17. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell. Hänsch GM; Hammer CH; Mayer MM; Shin ML J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149 [TBL] [Abstract][Full Text] [Related]
18. Human platelet-initiated formation and uptake of the C5-9 complex of human complement. Zimmerman TS; Kolb WP J Clin Invest; 1976 Jan; 57(1):203-11. PubMed ID: 812888 [TBL] [Abstract][Full Text] [Related]
19. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway. Fearon DT; Austen KF; Ruddy S Rheumatology; 1975; 6():2-16. PubMed ID: 1105744 [No Abstract] [Full Text] [Related]
20. The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane. Hu VW; Esser AF; Podack ER; Wisnieski BJ J Immunol; 1981 Jul; 127(1):380-6. PubMed ID: 7240749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]